课题基金 / 基金详情

NATIONAL OSTEOPOROSIS RISK ASSESSMENT

NATIONAL OSTEOPOROSIS RISK ASSESSMENT
国家骨质疏松症风险评估
批准号:
6586813
负责人:
JAN M BRUDER
金额:
$23.48万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-12-01 至 2002-11-30

项目摘要

项目成果

JAN M BRUDER的其他基金

相似基金

相关文献

中文摘要
翻译
国家骨质疏松症风险评估(NORA)是一项公共卫生 该计划将创建一个纵向的、观察性的数据库 作为50万名绝经后妇女。从这些网站收集的数据 患者将提供机会进行纵向研究,以 检查骨质疏松的危险因素之间的关系,包括 低骨密度和患者预后,如骨密度的变化 和骨折风险。最初的目标是确定它们之间的关系 在多个骨骼部位的每个部位的骨密度测量与 患者骨折的长期和短期风险。这一分析将试图 将每个测量的增量预测值确定为 以及确定骨密度测量的组合,当在 结合其他风险因素信息,提供更具预测性和 评估患者总体骨折风险的经济有效的方法。
英文摘要
The National Osteoporosis Risk Assessment (NORA) is a public health initiative that will create a longitudinal, observational data base of as many as 500,000 post-menopausal women. The data collected from these patients will offer opportunities to conduct longitudinal research to examine the relationship between risk factors for osteoporosis including low bone mineral density and patient outcomes such as changes in BMD and fracture risk. The initial objective is to determine the relationship between BMD measurements at each of a number of skeletal sites and a patient's long and short term risk of fracture. This analysis will attempt to determine the incremental predictive value of each of the measurements as well as identify combinations of BMD measures that, when considered in conjunction with other risk factor information, offer a more predictive and cost-effective method of evaluating a patient's overall risk of fracture.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
GENETICS OF BONE DENSITY IN MEXICAN AMERICANS - CONTINUATION
GENETICS OF BONE DENSITY IN MEXICAN AMERICANS - CONTINUATION
PREVENTION OF BONE LOSS WITH ALENDRONATE IN PROSTATE CANCER WITH HORMONE DEPRIVA
GENETICS OF BONE DENSITY IN MEXICAN AMERICANS - CONTINUATION
海外基金